|Articles|April 14, 2003
Preliminary trials with Light-Adjustable Lens are promising
San Francisco-April 13-The Light-Adjustable Lens (LAL) has entered humanclinical trials with promising results. Four humans-one blind and threewith sight-have received the lens, noted Robert K. Maloney, MD, chief medicalofficer, Calhoun Vision Inc, Pasadena, CA, who spoke at dinner gatheringin San Francisco.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
2
Metformin use associated with reduced incidence of intermediate AMD
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5
























